Skyrizi

Product

Last mentioned: Mar 24, 2026

Stories mentioning Skyrizi 2

UCB Commits $2B to Atlanta Manufacturing Hub Amid Biologic Growth

Belgian biopharma giant UCB has announced a massive $2 billion investment to establish a new manufacturing plant in suburban Atlanta, creating 330 high-skilled jobs. The move strengthens UCB's U.S. footprint as it scales production for its high-growth immunology portfolio.

Mar 24, 2026 2 sources

pharma Neutral

RBC Capital Initiates AbbVie Coverage with Outperform Rating

RBC Capital has launched coverage of pharmaceutical giant AbbVie with an Outperform rating, signaling confidence in the company's growth trajectory. The initiation suggests that market concerns regarding biosimilar competition for Humira are overstated as newer immunology assets gain significant market share.

Feb 27, 2026 2 sources